Kyoo-rok Han
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
A Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia.
Journal: Journal of clinical medicine
Published: December 06, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity.
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity.
Journal: JAMA cardiology
Published: November 27, 2024
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Journal: Clinical therapeutics
Published: January 09, 2024
Correction: Comparison of 2‑year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry.
Journal: Cardiovascular diabetology
Published: June 29, 2023
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: May 09, 2023
Body Mass Index and Major Adverse Events During Chronic Antiplatelet Monotherapy After Percutaneous Coronary Intervention With Drug-Eluting Stents - Results From the HOST-EXAM Trial.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: September 19, 2022
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function.
Journal: JACC. Asia
Published: June 06, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI".
Journal: Korean circulation journal
Published: June 03, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.
Journal: Clinical therapeutics
Published: June 03, 2022
Public Reporting on the Quality of Care in Patients with Acute Myocardial Infarction: The Korean Experience.
Journal: International journal of environmental research and public health
Published: November 29, 2021
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI.
Journal: Korean circulation journal
Published: August 30, 2021
Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV Study.
Journal: Clinical therapeutics
Published: April 04, 2020
Last Updated: 09/26/2026